The occurrence of depressive symptoms in rheumatoid arthritis: a cross-sectional study

  • Sonja Golubović University of Novi Sad, Faculty of Medicine, Novi Sad, Serbia
  • Tatjana Ilić University of Novi Sad, Faculty of Medicine, Novi Sad, Serbia
  • Boris Golubović University of Novi Sad, Faculty of Medicine, Novi Sad, Serbia
  • Milica Gajić Polyclinic “Novakov and Associates”, Novi Sad, Serbia
  • Zoran Gajić University of Novi Sad, Faculty of Medicine, Novi Sad, Serbia
Keywords: age factors, arthritis, rheumatoid, depression, residence characteristics, severity of illness index, work

Abstract


Background/Aim. Depression, as a common comorbidity in patients with rheumatoid arthritis (RA), has been found to affect the disease diagnosis and treatment response. Accordingly, the aim of the study was to investigate the occurrence of depressive symptoms among patients with RA and the association between RA and depression. Methods. The cross-sectional study included 69 patients with RA. The depressive symptoms in patients with RA were assessed using the Beck Depression Inventory (BDI), and RA activity was measured by Disease Activity Score-28 for RA with erythrocyte sedimentation rate (DAS28-ESR) and Clinical Disease Activity Index (CDAI). Results. It was found that 42% of respondents reported having depressive symptoms of different severity, among which the majority (23.2%) presented with mild symptoms. A mild positive correlation was found between the BDI and the DAS28-ESR (r = 0.39 p = 0.001), as well as between the BDI and the CDAI (r = 0.40 p = 0.001). Place of residence (t = -2.14 p = 0.03) and employment status (t = -2.81 p = 0.00) associated with depressive symptoms were also found to have statistically significant differences within the group of respondents. In addition, age had a positive correlation with the disease activity, as well as the place of residence and employment status. Conclusion. It has been observed that depressive symptoms in patients with RA were associated with disease activity, employment status, and place of residence. Therefore, there is an important need for integrating rheumatologic and mental health services for future research toward a better understanding of both depression and RA.

References

1.      Lipsky PE. Rheumatoid arthritis. In: Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL, editors. Harrison's principles of internal medicine. 15th ed. New York, NY: McGraw-Hill; 2001. p. 1928‒37.

2.      Helmick CG, Felson DT, Lawrence RC, Gabriel S, Hirsch R, Kwoh CK, et al. National Arthritis Data Workgroup. Estimates of the occurence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis Rheum 2008; 58(1): 15‒25.

3.      Humphreys JH, Verstappen SM, Hyrich KL, Chipping JR, Marshall T, Symmons DP. The incidence of rheumatoid arthritis in the UK: comparisons using the 2010 ACR/EULAR classification criteria and the 1987 ACR classification criteria. Results from the Norfolk Arthritis Register. Ann Rheum Dis 2013; 72(8): 1315‒20.

4.      Isik A, Koca SS, Ozturk A, Mermi O. Anxiety and depression in patients with rheumatoid arthritis. Clin Rheumatol 2007; 26(6): 872‒8.

5.      Margaretten M, Julian L, Katz P, Yelin E. Depression in patients with rheumatoid arthritis: description, causes and mechanisms. Int J Clin Rheumtol 2011; 6(6): 617‒23.

6.      Morris A, Yelin EH, Panopalis P, Julian L, Katz PP. Long-term patterns of depression and associations with health and function in a panel study of rheumatoid arthritis. J Health Psychol 2011; 16(4): 667‒77.

7.      Zyrianova Y, Kelly BD, Gallagher C, McCarthy C, Molloy MG, Sheehan J, et al. Depression and anxiety in rheumatoid arthritis: the role of perceived social support. Ir J Med Sci 2006; 175(2): 32‒6.

8.      Rathbun AM, Reed GW, Harrold LR. The temporal relationship between depression and rheumatoid arthritis disease activity, treatment persistence and response: a systematic review. Rheumatology (Oxford) 2013; 52(10): 1785‒94.

9.      Matcham F, Ali S, Irving K, Hotopf M, Chalder T. Are depression and anxiety associated with disease activity in rheumatoid arthritis? A prospective study. BMC Musculoskelet Disord 2016; 17: 155.

10.   Sautner J, Puchner R, Alkin A, Pieringer H. Depression: a common comorbidity in women with rheumatoid arthritis-results from an Austrian cross-sectional study. BMJ Open 2020; 10(1): e033958.

11.   Furner SE, Hootman JM, Helmick CG, Bolen J, Zack MM. Health-related quality of life of US adults with arthritis: analysis of data from the behavioral risk factor surveillance system, 2003, 2005, and 2007. Arthritis Care Res (Hoboken) 2011; 63(6): 788‒99.

12.   Newmann JP. Aging and depression. Psychol Aging 1989; 4(2): 150‒65.

13.   Katz PP, Yelin EH. Activity loss and the onset of depressive symptoms: do some activities matter more than others? Arthritis Rheum 2001; 44(5): 1194‒202.

14.   Moll LT, Gormsen L, Pfeiffer-Jensen M. Higher occurence of depression in patients with rheumatoid arthritis - a systematic review. Ugeskr Laeger 2011; 173(41): 2564‒8. (Danish)

15.   Hurwicz ML, Berkanovic E. The stress process in rheumatoid arthritis. J Rheumatol 1993; 20(11): 1836‒44.

16.   Young LD. Psychological factors in rheumatoid arthritis. J Consult Clin Psychol 1992; 60(4): 619‒27.

17.   van der Heijde DM, van 't Hof MA, van Riel PL, Theunisse LA, Lubberts EW, van Leeuwen MA, et al. Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score. Ann Rheum Dis 1990; 49(11): 916‒20.

18.   van Riel PL, Renskers L. The Disease Activity Score (DAS) and the Disease Activity Score using 28 joint counts (DAS28) in the management of rheumatoid arthritis. Clin Exp Rheumatol 2016; 34(5 Suppl 101): S40‒S44.

19.   Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2010; 62(9): 2569‒81.

20.   Smolen JS, Aletaha D. Scores for all seasons: SDAI and CDAI. Clin Exp Rheumatol 2014; 32(5 Suppl 85): S75‒9.

21.   Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961; 4: 561‒71.

22.  Novović Z, Mihić L, Tovilović S, Jovanović V, Biro M. Psychometric characteristics of the Beck depression inventory on a Serbian student sample. Psihologija 2011; 44(3): 225–43. (Serbian)

23.   Zich JM, Attkisson CC, Greenfield TK. Screening for depression in primary care clinics: the CES-D and the BDI. Int J Psychiatry Med 1990; 20(3): 259‒77.

24.   Beck AT, Steer RA, Carbin MG. Psychometric properties of the Beck Depression Inventory: Twenty-five years of evaluation. Clin Psychol Rev 1988; 8(1): 77‒100.

25.   Sokka T, Toloza S, Cutolo M, Kautiainen H, Makinen H, Gogus F, et al. Women, men, and rheumatoid arthritis: analyses of disease activity, disease characteristics, and treatments in the QUEST-RA study. Arthritis Res Ther 2009; 11(1): R7.

26.   Lopes FHA, Freitas MVC, de Bruin VMS, de Bruin PFC. Depressive symptoms are associated with impaired sleep, fatigue, and disease activity in women with rheumatoid arthritis. Adv Rheumatol. 2021; 61(1): 18.

27.   Tomasević-Todorovic S, Bosković K, Filipović D, Naumović N. Assessment of memory in patients with rheumatoid arthritis. Vojnosanit Pregl 2011; 68(6): 481‒8. (Serbian)

28.   Radovits BJ, Fransen J, van Riel PL, Laan RF. Influence of age and gender on the 28-joint Disease Activity Score (DAS28) in rheumatoid arthritis. Ann Rheum Dis 2008; 67(8): 1127‒31.

29.   van Onna M, Putrik P, Lie E, Kvien TK, Boonen A, Uhlig T. What do we measure with 28-joint DAS in elderly patients? An explorative analysis in the NOR-DMARD study. Rheumatology (Oxford) 2020; 59(7): 1622‒5.

30.   Fragoulis GE, Cavanagh J, Tindell A, Derakhshan M, Paterson C, Porter D, et al. Depression and anxiety in an early rheumatoid arthritis inception cohort. associations with demographic, socioeconomic and disease features. RMD Open 2020; 6(3): e001376.

31.  Matcham F, Rayner L, Steer S, Hotopf M. The prevalence of depression in rheumatoid arthritis: a systematic review and meta-analysis. Rheumatology (Oxford) 2013; 52(12): 2136‒48.

32.   Movahedi M, Joshi R, Rampakakis E, Thorne C, Cesta A, Sampalis JS, et al. Other OBRI Investigators. Impact of residential area on the management of rheumatoid arthritis patients initiating their first biologic DMARD: Results from the Ontario Best Practices Research Initiative (OBRI). Medicine (Baltimore) 2019; 98(20): e15517.

33.   Cornelissen PG, Rasker JJ, Valkenburg HA. The arthritis sufferer and the community: a comparison of arthritis sufferers in rural and urban areas. Ann Rheum Dis 1988; 47(2): 150‒6.

34.   Mella LF, Bértolo MB, Dalgalarrondo P. Depressive symptoms in rheumatoid arthritis. Braz J Psychiatry 2010; 32(3): 257‒63.

Published
2023/04/05
Section
Original Paper